These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19452382)

  • 1. Pregabalin in the treatment of schizophrenic anxiety.
    Schönfeldt-Lecuona C; Wolf RC; Osterfeld ND; Vasic N; Connemann BJ; Schmid M; Freudenmann RW
    Pharmacopsychiatry; 2009 May; 42(3):124-5. PubMed ID: 19452382
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [No evidence for tolerance in the treatment of anxiety with pregabalin (Lyrica)].
    Andersson M; Lindh J
    Lakartidningen; 2010 Apr 28-May 4; 107(17):1161. PubMed ID: 20518384
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
    Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
    Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generalized anxiety disorder with comorbidity. Treatment with pregabalin].
    Lauer D; Hölzel L; Hornyak M
    Nervenarzt; 2006 Nov; 77(11):1363, 1365-7. PubMed ID: 16786360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder.
    Oulis P; Kouzoupis AV; Koulouris G; Masdrakis VG; Kontoangelos K; Matsoukas T; Papadimitriou GN
    J Clin Psychopharmacol; 2008 Jun; 28(3):362-63. PubMed ID: 18480692
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregabalin in benzodiazepine withdrawal.
    Biermann T; Bleich S; Kornhuber J; Hillemacher T
    Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
    Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
    J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clarification about pregabalin and the Norwegian Prescription Database].
    Landmark CJ; Larsson PG; Rytter E; Johannessen SI
    Tidsskr Nor Laegeforen; 2011 May; 131(8):800-1. PubMed ID: 21556068
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregabalin-associated increase of clozapine serum levels.
    Englisch S; Alm B; Meyer-Lindenberg A; Zink M
    J Clin Psychopharmacol; 2012 Feb; 32(1):127. PubMed ID: 22217943
    [No Abstract]   [Full Text] [Related]  

  • 17. [To misunderstand about pregabalin abuse].
    Westin AA; Helland A; Strøm EJ
    Tidsskr Nor Laegeforen; 2011 Apr; 131(7):663. PubMed ID: 21494291
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for generalised anxiety disorder.
    Drug Ther Bull; 2010 Feb; 48(2):19-22. PubMed ID: 20147432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prescription registry and abuse of pregabalin].
    Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):223. PubMed ID: 21304565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.